Trend in approval of targeted biologics in the last two decades
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.
Κύριος συγγραφέας: | Siddika, Khadiza |
---|---|
Άλλοι συγγραφείς: | Ahmed, Syeda Maliha |
Μορφή: | Thesis |
Γλώσσα: | English |
Έκδοση: |
Brac University
2024
|
Θέματα: | |
Διαθέσιμο Online: | http://hdl.handle.net/10361/24296 |
Παρόμοια τεκμήρια
-
Targeted therapeutic options in the treatment of Breast Cancer
ανά: Alam, Kazi Tasnuva
Έκδοση: (2022) -
Study on anticancer drugs approved by the FDA from 2014 to 2023
ανά: Rattry, Faria Rahman
Έκδοση: (2024) -
Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
ανά: Tania, Umme
Έκδοση: (2023) -
RIPK pathway, as a potential target, for cancer treatment - a review
ανά: Jahan, Nusrat
Έκδοση: (2024) -
Molecular biology : genes to proteins /
ανά: Tropp, Burton E.
Έκδοση: (2008)